Sphingosylphosphorylcholine stimulates CCL2 production from human umbilical vein endothelial cells

Journal of Immunology

Volumn 186, Issue 7, 2011, Pages 4347-4353

  Lee, Ha Young ^a   Lee, Sun Young ^b,e   Kim, Sang Doo ^b,c   Shim, Jae Woong ^b,c   Kim, Hak Jung ^b,c   Jung, Young Su ^b,c   Kwon, Jae Young ^b   Baek, Suk Hwan ^d   Chung, Junho ^a   Bae, Yoe Sik ^b,c  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Dong A University   (South Korea)

^d Yeungnam University College of Medicine   (South Korea)

^e Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; SPHINGOSYLPHOSPHORYLCHOLINE; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UMBILICAL VEIN ENDOTHELIAL CELL;

CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; HUMANS; MEMBRANE LIPIDS; PERTUSSIS TOXIN; PHOSPHORYLCHOLINE; SIGNAL TRANSDUCTION; SPHINGOSINE; UMBILICAL VEINS;

EID: 79955033806     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002068     Document Type: Article

References (36)

1. Li, A. C., and C. K. Glass. 2002. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 8: 1235-1242. (Pubitemid 35373554)
2. Smith, J. D., E. Trogan, M. Ginsberg, C. Grigaux, J. Tian, and M. Miyata. 1995. Decreased atherosclerosis in mice deficient in both macrophage colonystimulating factor (op) and apolipoprotein E. Proc. Natl. Acad. Sci. USA 92: 8264-8268.
3. Valente, A. J., D. T. Graves, C. E. Vialle-Valentin, R. Delgado, and C. J. Schwartz. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27: 4162-4168.
4. Gosling, J., S. Slaymaker, L. Gu, S. Tseng, C. H. Zlot, S. G. Young, B. J. Rollins, and I. F. Charo. 1999. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103: 773-778. (Pubitemid 29152622)
5. Boring, L., J. Gosling, M. Cleary, and I. F. Charo. 1998. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897. (Pubitemid 28410911)
6. Inoue, S., K. Egashira, W. Ni, S. Kitamoto, M. Usui, K. Otani, M. Ishibashi, K. Hiasa, K. Nishida, and A. Takeshita. 2002. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 106: 2700-2706. (Pubitemid 35364925)
7. Victor, V. M., M. Rocha, E. Solá, C. Bañuls, K. Garcia-Malpartida, and A. Hernández-Mijares. 2009. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr. Pharm. Des. 15: 2988-3002.
8. Nakamura, N., M. Yoshida, M. Umeda, Y. Huang, S. Kitajima, Y. Inoue, I. Ishikawa, and T. Iwai. 2008. Extended exposure of lipopolysaccharide fraction from Porphyromonas gingivalis facilitates mononuclear cell adhesion to vascular endothelium via Toll-like receptor-2 dependent mechanism. Atherosclerosis 196: 59-67.
9. Sprague, A. H., and R. A. Khalil. 2009. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem. Pharmacol. 78: 539-552.
10. Braunersreuther, V., F. Mach, and S. Steffens. 2007. The specific role of chemokines in atherosclerosis. Thromb. Haemost. 97: 714-721. (Pubitemid 46804314)
11. Nixon, G. F., F. A. Mathieson, and I. Hunter. 2008. The multi-functional role of sphingosylphosphorylcholine. Prog. Lipid Res. 47: 62-75. (Pubitemid 350216623)
12. Okajima, F., and Y. Kondo. 1995. Pertussis toxin inhibits phospholipase C activation and Ca2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids. J. Biol. Chem. 270: 26332-26340.
13. Lee, H. Y., S. D. Kim, J. W. Shim, S. Y. Lee, H. Lee, K. H. Cho, J. Yun, and Y. S. Bae. 2008. Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes. J. Immunol. 181: 4332-4339.
14. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
15. Huber, J., A. Fürnkranz, V. N. Bochkov, M. K. Patricia, H. Lee, C. C. Hedrick, J. A. Berliner, B. R. Binder, and N. Leitinger. 2006. Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase. J. Lipid Res. 47: 1054-1062. (Pubitemid 43764701)
16. Srinivasan, S., M. Yeh, E. C. Danziger, M. E. Hatley, A. E. Riggan, N. Leitinger, J. A. Berliner, and C. C. Hedrick. 2003. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ. Res. 92: 371-377. (Pubitemid 36298196)
17. Jin, Y., B. B. Damaj, and A. A. Maghazachi. 2005. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and plateletactivating factor. Eur. J. Immunol. 35: 2699-2708. (Pubitemid 41404053)
18. Esteban, V., M. Ruperez, E. Sánchez-López, J. Rodríguez-Vita, O. Lorenzo, H. Demaegdt, P. Vanderheyden, J. Egido, and M. Ruiz-Ortega. 2005. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells. Circ. Res. 96: 965-973. (Pubitemid 40712796)
19. Boekhoudt, G. H., Z. Guo, G. W. Beresford, and J. M. Boss. 2003. Communication between NF-kappa B and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene. J. Immunol. 170: 4139-4147. (Pubitemid 36428178)
20. Abraham, E. 2000. NF-kappaB activation. Crit. Care Med. 28(4 Suppl): N100-N104.
21. Ishizuka, T., S. Sawada, K. Sugama, and A. Kurita. 2000. Thromboxane A2 (TXA2) receptor blockade suppresses monocyte chemoattractant protein-1 (MCP-1) expression by stimulated vascular endothelial cells. Clin. Exp. Immunol. 120: 71-78. (Pubitemid 30176902)
22. Johnson, G. L., and R. Lapadat. 2002. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912. (Pubitemid 35425238)
23. Hebenstreit, D., J. Horejs-Hoeck, and A. Duschl. 2005. JAK/STAT-dependent gene regulation by cytokines. Drug News Perspect. 18: 243-249. (Pubitemid 41094927)
24. Galkina, E., and K. Ley. 2007. Vascular adhesion molecules in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27: 2292-2301. (Pubitemid 350203942)
25. Beil, M., A. Micoulet, G. von Wichert, S. Paschke, P. Walther, M. B. Omary, P. P. Van Veldhoven, U. Gern, E. Wolff-Hieber, J. Eggermann, et al. 2003. Sphingosylphosphorylcholine regulates keratin network architecture and viscoelastic properties of human cancer cells. Nat. Cell Biol. 5: 803-811. (Pubitemid 37087168)
26. Nofer, J. R., M. van der Giet, M. Tölle, I. Wolinska, K. von Wnuck Lipinski, H. A. Baba, U. J. Tietge, A. Gödecke, I. Ishii, B. Kleuser, et al. 2004. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J. Clin. Invest. 113: 569-581. (Pubitemid 38542506)
27. Scanu, A. M., and C. Edelstein. 2008. HDL: Bridging past and present with a look at the future. FASEB J. 22: 4044-4054.
28. Florentin, M., E. N. Liberopoulos, A. S. Wierzbicki, and D. P. Mikhailidis. 2008. Multiple actions of high-density lipoprotein. Curr. Opin. Cardiol. 23: 370-378. (Pubitemid 351787103)
29. Murphy, A. J., and K. J. Woollard. 2010. High-density lipoprotein: A potent inhibitor of inflammation. Clin. Exp. Pharmacol. Physiol. 37: 710-718.
30. Meyers, C. D., and M. L. Kashyap. 2004. Pharmacologic elevation of highdensity lipoproteins: Recent insights on mechanism of action and atherosclerosis protection. Curr. Opin. Cardiol. 19: 366-373. (Pubitemid 38916496)
31. Tölle, M., A. Pawlak, M. Schuchardt, A. Kawamura, U. J. Tietge, S. Lorkowski, P. Keul, G. Assmann, J. Chun, B. Levkau, et al. 2008. HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production. Arterioscler. Thromb. Vasc. Biol. 28: 1542-1548.
32. Schmidt, A., S. Geigenmüller, W. Völker, and E. Buddecke. 2006. The antiatherogenic and antiinflammatory effect of HDL-associated lysosphingolipids operates via Akt -.NF-kappaB signalling pathways in human vascular endothelial cells. Basic Res. Cardiol. 101: 109-116. (Pubitemid 43250802)
33. Xu, Y., Y. J. Xiao, L. M. Baudhuin, and B. M. Schwartz. 2001. The role and clinical applications of bioactive lysolipids in ovarian cancer. J. Soc. Gynecol. Investig. 8: 1-13.
34. Jeon, E. S., Y. J. Kang, H. Y. Song, D. S. Im, H. S. Kim, S. H. Ryu, Y. K. Kim, and J. H. Kim. 2005. Sphingosylphosphorylcholine generates reactive oxygen species through calcium-, protein kinase Cdelta- and phospholipase D-dependent pathways. Cell. Signal. 17: 777-787. (Pubitemid 40250178)
35. Jeon, E. S., M. J. Lee, S. M. Sung, and J. H. Kim. 2007. Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen speciesmediated activation of ERK. J. Cell. Biochem. 100: 1536-1547. (Pubitemid 46515585)
36. Fernandez-Borja, M., J. D. van Buul, and P. L. Hordijk. 2010. The regulation of leucocyte transendothelial migration by endothelial signalling events. Cardiovasc. Res. 86: 202-210.